GlassScriptPhysician profile
Richard Anthony Visci
NPI 1386667194
$5,367.51
in general payments reported to CMS, 2019-2025
39 companies · $830 in 2025
The $830 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $186 · 2021: $464 · 2022: $1,323 · 2023: $1,127 · 2024: $615 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,307 · Education: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,307.21 |
| Education | $264.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $809.58 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $615.52 | 2019-2024 | Liletta, Lo Loestrin Fe, Ubrelvy |
| Organon LLC | $395.82 | 2021-2025 | Nexplanon, Jada System, Nuvaring |
| Amgen INC. | $356.47 | 2019-2025 | Evenity, Prolia |
| Applied Medical Resources Corporation | $248.08 | 2022 | |
| Sumitomo Pharma America, INC. | $230.19 | 2023-2025 | Myfembree |
| Pfizer INC. | $222.61 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $208.63 | 2021-2025 | |
| Daiichi Sankyo INC. | $206.16 | 2019-2024 | Injectafer |
| Hologic Sales and Service, LLC | $201.17 | 2019-2025 | Aptima, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $193.82 | 2021-2025 | Slynd |
| Covidien LP | $177.75 | 2019 | |
| Medtronic, INC. | $162.63 | 2021-2025 | Interstim |
| Sage Therapeutics, LLC | $161.00 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $160.55 | 2019-2023 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $141.57 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $120.02 | 2022 | |
| Amag Pharmaceuticals, INC. | $102.25 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $77.61 | 2024-2025 | Exparel |
| Agile Therapeutics, INC. | $72.53 | 2021-2023 | Twirla |
| Allergan, INC. | $57.79 | 2019 | |
| Avion Pharmaceuticals | $53.95 | 2021-2022 | |
| Therapeuticsmd, INC. | $47.62 | 2019-2021 | |
| Axonics, INC. | $44.48 | 2023-2024 | Axonics |
| Myovant Sciences INC. | $42.19 | 2022 | |
| Ethicon US, LLC | $39.55 | 2019-2022 | |
| Optumhealth Care Solutions, LLC | $30.46 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Currax Pharmaceuticals LLC | $28.68 | 2022-2023 | Contrave |
| Mylan Pharmaceuticals INC. | $17.38 | 2021 | |
| Kci USA, INC. | $16.79 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.86 | 2025 | Xifaxan |
| Supernus Pharmaceuticals, INC. | $15.59 | 2025 | Qelbree |
| Minerva Surgical, INC | $15.52 | 2023 | |
| Duchesnay USA Incorporated | $15.10 | 2019 | |
| Scynexis, INC. | $14.36 | 2022 | |
| Medtronic USA, INC. | $13.04 | 2020 | |
| Medline Industries LP | $12.04 | 2021 | |
| Lupin INC. | $12.00 | 2019 | |
| Merck Sharp & Dohme LLC | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Visci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.